Groupama Asset Managment Increases Position in CVS Health Corporation $CVS

Groupama Asset Managment increased its stake in shares of CVS Health Corporation (NYSE:CVS) by 112.4% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 18,525 shares of the pharmacy operator’s stock after purchasing an additional 9,803 shares during the quarter. Groupama Asset Managment’s holdings in CVS Health were worth $1,269,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in CVS. Vanguard Group Inc. lifted its position in shares of CVS Health by 1.7% during the second quarter. Vanguard Group Inc. now owns 120,399,131 shares of the pharmacy operator’s stock valued at $8,305,132,000 after buying an additional 2,063,737 shares during the last quarter. Dodge & Cox lifted its position in CVS Health by 4.8% during the first quarter. Dodge & Cox now owns 73,459,122 shares of the pharmacy operator’s stock valued at $4,976,856,000 after acquiring an additional 3,353,223 shares during the last quarter. Geode Capital Management LLC boosted its stake in CVS Health by 2.4% in the second quarter. Geode Capital Management LLC now owns 28,635,233 shares of the pharmacy operator’s stock valued at $1,966,083,000 after acquiring an additional 675,824 shares in the last quarter. Invesco Ltd. grew its holdings in CVS Health by 13.2% in the first quarter. Invesco Ltd. now owns 20,413,853 shares of the pharmacy operator’s stock worth $1,383,039,000 after purchasing an additional 2,375,764 shares during the last quarter. Finally, Price T Rowe Associates Inc. MD increased its position in shares of CVS Health by 14.5% during the first quarter. Price T Rowe Associates Inc. MD now owns 15,309,289 shares of the pharmacy operator’s stock worth $1,037,205,000 after purchasing an additional 1,942,886 shares in the last quarter. Hedge funds and other institutional investors own 80.66% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts recently weighed in on CVS shares. Baird R W upgraded CVS Health from a “hold” rating to a “strong-buy” rating in a research note on Thursday, August 14th. Zacks Research lowered CVS Health from a “strong-buy” rating to a “hold” rating in a research note on Monday, September 8th. Mizuho increased their price objective on shares of CVS Health from $76.00 to $88.00 and gave the company an “outperform” rating in a research report on Thursday, October 9th. Royal Bank Of Canada boosted their target price on shares of CVS Health from $81.00 to $93.00 and gave the stock an “outperform” rating in a research report on Thursday, October 30th. Finally, Barclays raised their price target on shares of CVS Health from $80.00 to $87.00 and gave the stock an “overweight” rating in a report on Thursday, September 4th. Two research analysts have rated the stock with a Strong Buy rating, twenty-one have given a Buy rating and four have issued a Hold rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $89.41.

CVS Health Stock Up 0.2%

CVS stock opened at $80.03 on Friday. The company has a market capitalization of $101.60 billion, a P/E ratio of 210.62, a price-to-earnings-growth ratio of 0.87 and a beta of 0.60. CVS Health Corporation has a 12 month low of $43.56 and a 12 month high of $85.15. The firm’s fifty day simple moving average is $78.64 and its 200-day simple moving average is $70.77. The company has a debt-to-equity ratio of 0.83, a current ratio of 0.83 and a quick ratio of 0.62.

CVS Health (NYSE:CVS) last posted its earnings results on Wednesday, October 29th. The pharmacy operator reported $1.60 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.36 by $0.24. The company had revenue of $102.87 billion during the quarter, compared to the consensus estimate of $98.85 billion. CVS Health had a net margin of 0.12% and a return on equity of 11.45%. The firm’s quarterly revenue was up 7.8% on a year-over-year basis. During the same period in the previous year, the firm posted $1.09 earnings per share. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. As a group, equities research analysts forecast that CVS Health Corporation will post 5.89 earnings per share for the current year.

CVS Health Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Monday, November 3rd. Investors of record on Thursday, October 23rd were issued a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a yield of 3.3%. The ex-dividend date of this dividend was Thursday, October 23rd. CVS Health’s dividend payout ratio (DPR) is 700.00%.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.